101. Belzil, V.V.; Bauer, P.O.; Prudencio, M.; Gendron, T.F.; Stetler, C.T.; Yan, I.K.; Pregent, L.; Daughrity, L.; Baker, M.C.; Rademakers, R.; et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. *Acta Neuropathol.* **2013**, *126*, 895–905. [CrossRef]

102. Frick, P.; Sellier, C.; Mackenzie, I.R.A.; Cheng, C.Y.; Tahraoui-Bories, J.; Martinat, C.; Pasterkamp, R.J.; Prudlo, J.; Edbauer, D.; Oulad-Abdelghani, M.; et al. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. *Acta Neuropathol. Commun.* **2018**, *6*, 72. [CrossRef] [PubMed]

103. Waite, A.J.; Bäumer, D.; East, S.; Neal, J.; Morris, H.R.; Ansorge, O.; Blake, D.J. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. *Neurobiol. Aging* **2014**, *35*, 1779. [CrossRef] [PubMed]

104. Ciura, S.; Lattante, S.; Le Ber, I.; Latouche, M.; Tostivint, H.; Brice, A.; Kabashi, E. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. *Ann. Neurol.* **2013**, *74*, 180–187. [CrossRef]

105. Therrien, M.; Rouleau, G.A.; Dion, P.A.; Parker, J.A. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. *PLoS ONE* **2013**, *8*, e83450. [CrossRef] [PubMed]

106. O'Rourke, J.G.; Bogdanik, L.; Yáñez, A.; Lall, D.; Wolf, A.J.; Muhammad, A.K.; Ho, R.; Carmona, S.; Vit, J.P.; Zarrow, J.; et al. C9orf72 is required for proper macrophage and microglial function in mice. *Science (New York, NY)* **2016**, *351*, 1324–1329. [CrossRef] [PubMed]

107. Zhu, Q.; Jiang, J.; Gendron, T.F.; McAlonis-Downes, M.; Jiang, L.; Taylor, A.; Diaz Garcia, S.; Ghosh Dastidar, S.; Rodriguez, M.J.; King, P.; et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. *Nat. Neurosci.* **2020**, *23*, 615–624. [CrossRef] [PubMed]

108. Iyer, S.; Acharya, K.R.; Subramanian, V. A comparative bioinformatic analysis of C9orf72. *PeerJ* **2018**, *6*, e4391. [CrossRef]

109. Gendron, T.F.; Bieniek, K.F.; Zhang, Y.J.; Jansen-West, K.; Ash, P.E.; Caulfield, T.; Daughrity, L.; Dunmore, J.H.; Castanedes-Casey, M.; Chew, J.; et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. *Acta Neuropathol.* **2013**, *126*, 829–844. [CrossRef]

110. Goodman, L.D.; Prudencio, M.; Kramer, N.J.; Martinez-Ramirez, L.F.; Srinivasan, A.R.; Lan, M.; Parisi, M.J.; Zhu, Y.; Chew, J.; Cook, C.N.; et al. Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD. *Nat. Neurosci.* **2019**, *22*, 863–874. [CrossRef]

111. Kramer, N.J.; Carlomagno, Y.; Zhang, Y.J.; Almeida, S.; Cook, C.N.; Gendron, T.F.; Prudencio, M.; van Blitterswijk, M.; Belzil, V.; Couthouis, J.; et al. Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. *Science (New York, NY)* **2016**, *353*, 708–712. [CrossRef] [PubMed]

112. Xu, Z.; Poidevin, M.; Li, X.; Li, Y.; Shu, L.; Nelson, D.L.; Li, H.; Hales, C.M.; Gearing, M.; Wingo, T.S.; et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. *Proc. Natl. Acad. Sci. USA* **2013**, *110*, 7778–7783. [CrossRef] [PubMed]

113. Kanai, Y.; Dohmae, N.; Hirokawa, N. Kinesin transports RNA: Isolation and characterization of an RNA-transporting granule. *Neuron* **2004**, *43*, 513–525. [CrossRef] [PubMed]

114. Celona, B.; Dollen, J.V.; Vatsavayai, S.C.; Kashima, R.; Johnson, J.R.; Tang, A.A.; Hata, A.; Miller, B.L.; Huang, E.J.; Krogan, N.J.; et al. Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106. *eLife* **2017**, *6*, e19032. [CrossRef] [PubMed]

115. Zhang, K.; Donnelly, C.J.; Haeusler, A.R.; Grima, J.C.; Machamer, J.B.; Steinwald, P.; Daley, E.L.; Miller, S.J.; Cunningham, K.M.; Vidensky, S.; et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. *Nature* **2015**, *525*, 56–61. [CrossRef]

116. Burguete, A.S.; Almeida, S.; Gao, F.B.; Kalb, R.; Akins, M.R.; Bonini, N.M. GGGGCC microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function. *eLife* **2015**, *4*, e08881. [CrossRef] [PubMed]

117. Tran, H.; Almeida, S.; Moore, J.; Gendron, T.F.; Chalasani, U.; Lu, Y.; Du, X.; Nickerson, J.A.; Petrucelli, L.; Weng, Z.; et al. Differential Toxicity of Nuclear RNA Foci versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD/ALS. *Neuron* **2015**, *87*, 1207–1214. [CrossRef]

118. Moens, T.G.; Mizielinska, S.; Niccoli, T.; Mitchell, J.S.; Thoeng, A.; Ridler, C.E.; Grönke, S.; Esser, J.; Heslegrave, A.; Zetterberg, H.; et al. Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD. *Acta Neuropathol.* **2018**, *135*, 445–457. [CrossRef] [PubMed]

119. Mori, K.; Arzberger, T.; Grässer, F.A.; Gijselinck, I.; May, S.; Rentzsch, K.; Weng, S.M.; Schludi, M.H.; van der Zee, J.; Cruts, M.; et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. *Acta Neuropathol.* **2013**, *126*, 881–893. [CrossRef]

120. Mori, K.; Weng, S.M.; Arzberger, T.; May, S.; Rentzsch, K.; Kremmer, E.; Schmid, B.; Kretzschmar, H.A.; Cruts, M.; van Broeckhoven, C.; et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. *Science* **2013**, *339*, 1335–1338. [CrossRef]

121. Mizielinska, S.; Grönke, S.; Niccoli, T.; Ridler, C.E.; Clayton, E.L.; Devoy, A.; Moens, T.; Norona, F.E.; Woollacott, I.O.C.; Pietrzyk, J.; et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. *Science (New York, NY)* **2014**, *345*, 1192–1194. [CrossRef] [PubMed]
122. Wen, X.; Tan, W.; Westergard, T.; Krishnamurthy, K.; Markandaiah, S.S.; Shi, Y.; Lin, S.; Shneider, N.A.; Monaghan, J.; Pandey, U.B.; et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. *Neuron* **2014**, *84*, 1213–1225. [CrossRef] [PubMed]

123. Freibaum, B.D.; Lu, Y.; Lopez-Gonzalez, R.; Kim, N.C.; Almeida, S.; Lee, K.H.; Badders, N.; Valentine, M.; Miller, B.L.; Wong, P.C.; et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. *Nature* **2015**, *525*, 129–133. [CrossRef] [PubMed]

124. Lee, K.H.; Zhang, P.; Kim, H.J.; Mitrea, D.M.; Sarkar, M.; Freibaum, B.D.; Cika, J.; Coughlin, M.; Messing, J.; Molliex, A.; et al. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. *Cell* **2016**, *167*, 774–788. [CrossRef] [PubMed]

125. Perry, S.; Han, Y.; Das, A.; Dickman, D. Homeostatic plasticity can be induced and expressed to restore synaptic strength at neuromuscular junctions undergoing ALS-related degeneration. *Hum. Mol. Genet.* **2017**, *26*, 4153–4167. [CrossRef] [PubMed]

126. Yang, D.; Abdallah, A.; Li, Z.; Lu, Y.; Almeida, S.; Gao, F.B. FTD/ALS-associated poly(GR) protein impairs the Notch pathway and is recruited by poly(GA) into cytoplasmic inclusions. *Acta Neuropathol.* **2015**, *130*, 525–535. [CrossRef]

127. Morón-Oset, J.; Supèr, T.; Esser, J.; Isaacs, A.M.; Grönke, S.; Partridge, L. Glycine-alanine dipeptide repeats spread rapidly in a repeat length- and age-dependent manner in the fly brain. *Acta Neuropathol. Commun.* **2019**, *7*, 209. [CrossRef]

128. Boeynaems, S.; Bogaert, E.; Michiels, E.; Gijselinck, I.; Sieben, A.; Jovičić, A.; de Baets, G.; Scheveneels, W.; Steyaert, J.; Cuijt, I.; et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. *Sci. Rep.* **2016**, *6*, 20877. [CrossRef]

129. Moens, T.G.; Niccoli, T.; Wilson, K.M.; Atilano, M.L.; Birsa, N.; Gittings, L.M.; Holbling, B.V.; Dyson, M.C.; Thoeng, A.; Neeves, J.; et al. C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. *Acta Neuropathol.* **2019**, *137*, 487–500. [CrossRef]

130. Li, S.; Wu, Z.; Li, Y.; Tantray, I.; de Stefani, D.; Mattarei, A.; Krishnan, G.; Gao, F.B.; Vogel, H.; Lu, B. Altered MICOS Morphology and Mitochondrial Ion Homeostasis Contribute to Poly(GR) Toxicity Associated with C9-ALS/FTD. *Cell Rep.* **2020**, *32*, 107989. [CrossRef]

131. Simone, R.; Balendra, R.; Moens, T.G.; Preza, E.; Wilson, K.M.; Heslegrave, A.; Woodling, N.S.; Niccoli, T.; Gilbert-Jaramillo, J.; Abdelkarim, S.; et al. G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo. *EMBO Mol. Med.* **2018**, *10*, 22–31. [CrossRef] [PubMed]

132. Andersson, M.K.; Ståhlberg, A.; Arvidsson, Y.; Olofsson, A.; Semb, H.; Stenman, G.; Nilsson, O.; Aman, P. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. *BMC Cell Biol.* **2008**, *9*, 37. [CrossRef] [PubMed]

133. Guerrero, E.N.; Wang, H.; Mitra, J.; Hegde, P.M.; Stowell, S.E.; Liachko, N.F.; Kraemer, B.C.; Garruto, R.M.; Rao, K.S.; Hegde, M.L. TDP-43/FUS in motor neuron disease: Complexity and challenges. *Prog. Neurobiol.* **2016**, *145–146*, 78–97. [CrossRef] [PubMed]

134. Huang, C.; Zhou, H.; Tong, J.; Chen, H.; Liu, Y.J.; Wang, D.; Wei, X.; Xia, X.G. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. *PLoS Genet.* **2011**, *7*, e1002011. [CrossRef]

135. Naumann, M.; Pal, A.; Goswami, A.; Lojewski, X.; Japtok, J.; Vehlow, A.; Naujock, M.; Günther, R.; Jin, M.; Stanslowsky, N.; et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. *Nat. Commun.* **2018**, *9*, 335. [CrossRef]

136. Lagier-Tourenne, C.; Polymenidou, M.; Hutt, K.R.; Vu, A.Q.; Baughn, M.; Huelga, S.C.; Clutario, K.M.; Ling, S.C.; Liang, T.Y.; Mazur, C.; et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. *Nat. Neurosci.* **2012**, *15*, 1488–1497. [CrossRef]

137. Rogelj, B.; Easton, L.E.; Bogu, G.K.; Stanton, L.W.; Rot, G.; Curk, T.; Zupan, B.; Sugimoto, Y.; Modic, M.; Haberman, N.; et al. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. *Sci. Rep.* **2012**, *2*, 603. [CrossRef]

138. Tan, A.Y.; Manley, J.L. TLS inhibits RNA polymerase III transcription. *Mol. Cell. Biol.* **2010**, *30*, 186–196. [CrossRef]

139. Uranishi, H.; Tetsuka, T.; Yamashita, M.; Asamitsu, K.; Shimizu, M.; Itoh, M.; Okamoto, T. Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. *J. Biol. Chem.* **2001**, *276*, 13395–13401. [CrossRef]

140. Zinszner, H.; Sok, J.; Immanuel, D.; Yin, Y.; Ron, D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. *J. Cell Sci.* **1997**, *110* Pt 15, 1741–1750.

141. Lagier-Tourenne, C.; Cleveland, D.W. Rethinking ALS: The FUS about TDP-43. *Cell* **2009**, *136*, 1001–1004. [CrossRef] [PubMed]

142. Da Cruz, S.; Cleveland, D.W. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. *Curr. Opin. Neurobiol.* **2011**, *21*, 904–919. [CrossRef] [PubMed]

143. Corrado, L.; Del Bo, R.; Castellotti, B.; Ratti, A.; Cereda, C.; Penco, S.; Sorarù, G.; Carlomagno, Y.; Ghezzi, S.; Pensato, V.; et al. Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. *J. Med. Genet.* **2010**, *47*, 190–194. [CrossRef] [PubMed]

144. Dormann, D.; Rodde, R.; Edbauer, D.; Bentmann, E.; Fischer, I.; Hruscha, A.; Than, M.E.; Mackenzie, I.R.; Capell, A.; Schmid, B.; et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. *EMBO J.* **2010**, *29*, 2841–2857. [CrossRef] [PubMed]

145. Dini Modigliani, S.; Morlando, M.; Errichelli, L.; Sabatelli, M.; Bozzoni, I. An ALS-associated mutation in the FUS 3'-UTR disrupts a microRNA-FUS regulatory circuitry. *Nat. Commun.* **2014**, *5*, 4335. [CrossRef]
146. Sabatelli, M.; Moncada, A.; Conte, A.; Lattante, S.; Marangi, G.; Luigetti, M.; Lucchini, M.; Mirabella, M.; Romano, A.; Del Grande, A.; et al. Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. *Hum. Mol. Genet.* **2013**, *22*, 4748–4755. [CrossRef]

147. Chen, Y.; Yang, M.; Deng, J.; Chen, X.; Ye, Y.; Zhu, L.; Liu, J.; Ye, H.; Shen, Y.; Li, Y.; et al. Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. *Protein Cell* **2011**, *2*, 477–486. [CrossRef]

148. Kabashi, E.; Bercier, V.; Lissouba, A.; Liao, M.; Brustein, E.; Rouleau, G.A.; Drapeau, P. FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. *PLoS Genet.* **2011**, *7*, e1002214. [CrossRef]

149. Murakami, T.; Qamar, S.; Lin, J.Q.; Schierle, G.S.; Rees, E.; Miyashita, A.; Costa, A.R.; Dodd, R.B.; Chan, F.T.; Michel, C.H.; et al. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function. *Neuron* **2015**, *88*, 678–690. [CrossRef]

150. Sasayama, H.; Shimamura, M.; Tokuda, T.; Azuma, Y.; Yoshida, T.; Mizuno, T.; Nakagawa, M.; Fujikake, N.; Nagai, Y.; Yamaguchi, M. Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches. *PLoS ONE* **2012**, *7*, e39483. [CrossRef]

151. Zhou, Y.; Liu, S.; Liu, G.; Oztürk, A.; Hicks, G.G. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. *PLoS Genet.* **2013**, *9*, e1003895. [CrossRef] [PubMed]

152. Bosco, D.A.; Lemay, N.; Ko, H.K.; Zhou, H.; Burke, C.; Kwiatkowski, T.J., Jr.; Sapp, P.; McKenna-Yasek, D.; Brown, R.H., Jr.; Hayward, L.J. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. *Hum. Mol. Genet.* **2010**, *19*, 4160–4175. [CrossRef]

153. Li, Y.R.; King, O.D.; Shorter, J.; Gitler, A.D. Stress granules as crucibles of ALS pathogenesis. *J. Cell Biol.* **2013**, *201*, 361–372. [CrossRef] [PubMed]

154. Sun, Z.; Diaz, Z.; Fang, X.; Hart, M.P.; Chesi, A.; Shorter, J.; Gitler, A.D. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. *PLoS Biol.* **2011**, *9*, e1000614. [CrossRef] [PubMed]

155. Bourefis, A.R.; Campanari, M.L.; Buee-Scherrer, V.; Kabashi, E. Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS. *Neurobiol. Dis.* **2020**, *142*, 104935. [CrossRef] [PubMed]

156. Jackson, K.L.; Dhaibar, H.A.; Dayton, R.D.; Cananzi, S.G.; Mayhan, W.G.; Glasscock, E.; Klein, R.L. Severe respiratory changes at end stage in a FUS-induced disease state in adult rats. *BMC Neurosci.* **2016**, *17*, 69. [CrossRef]

157. Sharma, A.; Lyashchenko, A.K.; Lu, L.; Nasrabady, S.E.; Elmaleh, M.; Mendelsohn, M.; Nemes, A.; Tapia, J.C.; Mentis, G.Z.; Shneider, N.A. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. *Nat. Commun.* **2016**, *7*, 10465. [CrossRef]

158. Lanson, N.A., Jr.; Maltare, A.; King, H.; Smith, R.; Kim, J.H.; Taylor, J.P.; Lloyd, T.E.; Pandey, U.B. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. *Hum. Mol. Genet.* **2011**, *20*, 2510–2523. [CrossRef]

159. Wang, J.W.; Brent, J.R.; Tomlinson, A.; Shneider, N.A.; McCabe, B.D. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. *J. Clin. Investig.* **2011**, *121*, 4118–4126. [CrossRef]

160. Xia, R.; Liu, Y.; Yang, L.; Gal, J.; Zhu, H.; Jia, J. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS. *Mol. Neurodegener.* **2012**, *7*, 10. [CrossRef]

161. Bogaert, E.; Boeynaems, S.; Kato, M.; Guo, L.; Caulfield, T.R.; Steyaert, J.; Scheveneels, W.; Wilmans, N.; Haeck, W.; Hersmus, N.; et al. Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity. *Cell Rep.* **2018**, *24*, 529–537. [CrossRef] [PubMed]

162. Miguel, L.; Avequin, T.; Delarue, M.; Feuillette, S.; Frébourg, T.; Campion, D.; Lecourtois, M. Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila. *Neurobiol. Aging* **2012**, *33*, 1008. [CrossRef] [PubMed]

163. Deng, J.; Yang, M.; Chen, Y.; Chen, X.; Liu, J.; Sun, S.; Cheng, H.; Li, Y.; Bigio, E.H.; Mesulam, M.; et al. FUS Interacts with HSP60 to Promote Mitochondrial Damage. *PLoS Genet.* **2015**, *11*, e1005357. [CrossRef]

164. Jäckel, S.; Summerer, A.K.; Thömmes, C.M.; Pan, X.; Voigt, A.; Schulz, J.B.; Rasse, T.M.; Dormann, D.; Haass, C.; Kahle, P.J. Nuclear import factor transportin and arginine methyltransferase 1 modify FUS neurotoxicity in Drosophila. *Neurobiol. Dis.* **2015**, *74*, 76–88. [CrossRef] [PubMed]

165. Daigle, J.G.; Lanson, N.A., Jr.; Smith, R.B.; Casci, I.; Maltare, A.; Monaghan, J.; Nichols, C.D.; Kryndushkin, D.; Shewmaker, F.; Pandey, U.B. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. *Hum. Mol. Genet.* **2013**, *22*, 1193–1205. [CrossRef]

166. Steyaert, J.; Scheveneels, W.; Vanneste, J.; van Damme, P.; Robberecht, W.; Callaerts, P.; Bogaert, E.; van den Bosch, L. FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins. *Hum. Mol. Genet.* **2018**, *27*, 4103–4116. [CrossRef]

167. Gogia, N.; Sarkar, A.; Mehta, A.S.; Ramesh, N.; Deshpande, P.; Kango-Singh, M.; Pandey, U.B.; Singh, A. Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo. *Neurobiol. Dis.* **2020**, *140*, 104837. [CrossRef]

168. Machamer, J.B.; Collins, S.E.; Lloyd, T.E. The ALS gene FUS regulates synaptic transmission at the Drosophila neuromuscular junction. *Hum. Mol. Genet.* **2014**, *23*, 3810–3822. [CrossRef]
169. Shahidullah, M.; Le Marchand, S.J.; Fei, H.; Zhang, J.; Pandey, U.B.; Dalva, M.B.; Pasinelli, P.; Levitan, I.B. Defects in synapse structure and function precede motor neuron degeneration in Drosophila models of FUS-related ALS. *J. Neurosci.* **2013**, *33*, 19590–19598. [CrossRef]

170. Ito, D.; Seki, M.; Tsunoda, Y.; Uchiyama, H.; Suzuki, N. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. *Ann. Neurol.* **2011**, *69*, 152–162. [CrossRef]

171. Kino, Y.; Washizu, C.; Aquilanti, E.; Okuno, M.; Kurosawa, M.; Yamada, M.; Doi, H.; Nukina, N. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. *Nucleic Acids Res.* **2011**, *39*, 2781–2798. [CrossRef] [PubMed]

172. Lee, B.J.; Cansizoglu, A.E.; Süel, K.E.; Louis, T.H.; Zhang, Z.; Chook, Y.M. Rules for nuclear localization sequence recognition by karyopherin beta 2. *Cell* **2006**, *126*, 543–558. [CrossRef] [PubMed]

173. Stolow, D.T.; Haynes, S.R. Cabeza, a Drosophila gene encoding a novel RNA binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. *Nucleic Acids Res.* **1995**, *23*, 835–843. [CrossRef] [PubMed]

174. Xia, Q.; Wang, H.; Hao, Z.; Fu, C.; Hu, Q.; Gao, F.; Ren, H.; Chen, D.; Han, J.; Ying, Z.; et al. TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. *EMBO J.* **2016**, *35*, 121–142. [CrossRef]

175. Frickenhaus, M.; Wagner, M.; Mallik, M.; Catinozzi, M.; Storkebaum, E. Highly efficient cell-type-specific gene inactivation reveals a key function for the Drosophila FUS homolog cabeza in neurons. *Sci. Rep.* **2015**, *5*, 9107. [CrossRef]

176. Shimamura, M.; Kyotani, A.; Azuma, Y.; Yoshida, H.; Binh Nguyen, T.; Mizuta, I.; Yoshida, T.; Mizuno, T.; Nakagawa, M.; Tokuda, T.; et al. Genetic link between Cabeza, a Drosophila homologue of Fused in Sarcoma (FUS), and the EGFR signaling pathway. *Exp. Cell Res.* **2014**, *326*, 36–45. [CrossRef]

177. Azuma, Y.; Tokuda, T.; Kushimura, Y.; Yamamoto, I.; Mizuta, I.; Mizuno, T.; Nakagawa, M.; Ueyama, M.; Nagai, Y.; Iwasaki, Y.; et al. Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. *Exp. Cell Res.* **2018**, *371*, 311–321. [CrossRef]

178. Azuma, Y.; Tokuda, T.; Shimamura, M.; Kyotani, A.; Sasayama, H.; Yoshida, T.; Mizuta, I.; Mizuno, T.; Nakagawa, M.; Fujikake, N.; et al. Identification of ter94, Drosophila VCP, as a strong modulator of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS. *Hum. Mol. Genet.* **2014**, *23*, 3467–3480. [CrossRef]

179. Lo Piccolo, L.; Jantrapirom, S.; Nagai, Y.; Yamaguchi, M. FUS toxicity is rescued by the modulation of lncRNA hsrω expression in Drosophila melanogaster. *Sci. Rep.* **2017**, *7*, 15660. [CrossRef]

180. Wakisaka, K.T.; Tanaka, R.; Hirashima, T.; Muraoka, Y.; Azuma, Y.; Yoshida, H.; Tokuda, T.; Asada, S.; Suda, K.; Ichiyanagi, K.; et al. Novel roles for Drosophila FUS and Aub responsible for piRNA biogenesis in neuronal disorders. *Brain Res.* **2019**, *1708*, 207–219. [CrossRef]

181. Machamer, J.B.; Woolums, B.M.; Fuller, G.G.; Lloyd, T.E. FUS causes synaptic hyperexcitability in Drosophila dendritic arborization neurons. *Brain Res.* **2018**, *1693*, 55–66. [CrossRef]

182. Hirano, A.; Nakano, I.; Kurland, L.T.; Mulder, D.W.; Holley, P.W.; Saccomanno, G. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. *J. Neuropathol. Exp. Neurol.* **1984**, *43*, 471–480. [CrossRef] [PubMed]

183. Sasaki, S.; Horie, Y.; Iwata, M. Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis. *Acta Neuropathol.* **2007**, *114*, 633–639. [CrossRef] [PubMed]

184. Smith, E.F.; Shaw, P.J.; de Vos, K.J. The role of mitochondria in amyotrophic lateral sclerosis. *Neurosci. Lett.* **2019**, *710*, 132933. [CrossRef] [PubMed]

185. Altanbyek, V.; Cha, S.J.; Kang, G.U.; Im, D.S.; Lee, S.; Kim, H.J.; Kim, K. Imbalance of mitochondrial dynamics in Drosophila models of amyotrophic lateral sclerosis. *Biochem. Biophys. Res. Commun.* **2016**, *481*, 259–264. [CrossRef]

186. Chen, Y.; Deng, J.; Wang, P.; Yang, M.; Chen, X.; Zhu, L.; Liu, J.; Lu, B.; Shen, Y.; Fushimi, K.; et al. PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration. *Hum. Mol. Genet.* **2016**, *25*, 5059–5068. [CrossRef]

187. Mayer, M.P. Gymnastics of molecular chaperones. *Mol. Cell* **2010**, *39*, 321–331. [CrossRef]

188. Huang, S. Review: Perinucleolar structures. *J. Struct. Biol.* **2000**, *129*, 233–240. [CrossRef]

189. Mao, Y.S.; Zhang, B.; Spector, D.L. Biogenesis and function of nuclear bodies. *Trends Genet.* **2011**, *27*, 295–306. [CrossRef]

190. Meng, F.; Na, I.; Kurgan, L.; Uversky, V.N. Compartmentalization and Functionality of Nuclear Disorder: Intrinsic Disorder and Protein-Protein Interactions in Intra-Nuclear Compartments. *Int. J. Mol. Sci.* **2015**, *17*, 24. [CrossRef]

191. Ninomiya, K.; Hirose, T. Short Tandem Repeat-Enriched Architectural RNAs in Nuclear Bodies: Functions and Associated Diseases. *Non-Coding RNA* **2020**, *6*, 6. [CrossRef] [PubMed]

192. Chujo, T.; Yamazaki, T.; Hirose, T. Architectural RNAs (arcRNAs): A class of long noncoding RNAs that function as the scaffold of nuclear bodies. *Biochim. Biophys. Acta* **2016**, *1859*, 139–146. [CrossRef] [PubMed]

193. Sun, Q.; Hao, Q.; Prasanth, K.V. Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression. *Trends Genet.* **2018**, *34*, 142–157. [CrossRef] [PubMed]

194. Shelkovnikova, T.A.; Robinson, H.K.; Troakes, C.; Ninkina, N.; Buchman, V.L. Compromised paraspeckle formation as a pathogenic factor in FUSopathies. *Hum. Mol. Genet.* **2014**, *23*, 2298–2312. [CrossRef]

195. Jolly, C.; Lakhotia, S.C. Human sat III and Drosophila hsr omega transcripts: A common paradigm for regulation of nuclear RNA processing in stressed cells. *Nucleic Acids Res.* **2006**, *34*, 5508–5514. [CrossRef] [PubMed]
196. Onorati, M.C.; Lazzaro, S.; Mallik, M.; Ingrassia, A.M.; Carreca, A.P.; Singh, A.K.; Chaturvedi, D.P.; Lakhotia, S.C.; Corona, D.F. The ISWI chromatin remodeler organizes the hsrω ncRNA-containing omega speckle nuclear compartments. *PLoS Genet.* **2011**, *7*, e1002096. [CrossRef]

197. Piccolo, L.L.; Corona, D.; Onorati, M.C. Emerging roles for hnRNPs in post-transcriptional regulation: What can we learn from flies? *Chromosoma* **2014**, *123*, 515–527. [CrossRef]

198. Prasanth, K.V.; Rajendra, T.K.; Lal, A.K.; Lakhotia, S.C. Omega speckles—A novel class of nuclear speckles containing hnRNPs associated with noncoding hsr-omega RNA in Drosophila. *J. Cell Sci.* **2000**, *113* Pt 19, 3485–3497.

199. Singh, A.K.; Lakhotia, S.C. Dynamics of hnRNPs and omega speckles in normal and heat shocked live cell nuclei of Drosophila melanogaster. *Chromosoma* **2015**, *124*, 367–383. [CrossRef]

200. Terasawa, K.; Tomabechi, Y.; Ikeda, M.; Ehara, H.; Kukimoto-Niino, M.; Wakiyama, M.; Podyma-Inoue, K.A.; Rajapakshe, A.R.; Watabe, T.; Shirouzu, M.; et al. Lysosome-associated membrane proteins-1 and -2 (LAMP-1 and LAMP-2) assemble via distinct modes. *Biochem. Biophys. Res. Commun.* **2016**, *479*, 489–495. [CrossRef]

201. Burke, K.A.; Janke, A.M.; Rhine, C.L.; Fawzi, N.L. Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II. *Mol. Cell* **2015**, *60*, 231–241. [CrossRef] [PubMed]

202. Han, T.W.; Kato, M.; Xie, S.; Wu, L.C.; Mirzaei, H.; Pei, J.; Chen, M.; Xie, Y.; Allen, J.; Xiao, G.; et al. Cell-free formation of RNA granules: Bound RNAs identify features and components of cellular assemblies. *Cell* **2012**, *149*, 768–779. [CrossRef] [PubMed]

203. Kato, M.; Han, T.W.; Xie, S.; Shi, K.; Du, X.; Wu, L.C.; Mirzaei, H.; Goldsmith, E.J.; Longgood, J.; Pei, J.; et al. Cell-free formation of RNA granules: Low complexity sequence domains form dynamic fibers within hydrogels. *Cell* **2012**, *149*, 753–767. [CrossRef]

204. Lin, Y.; Protter, D.S.; Rosen, M.K.; Parker, R. Formation and Maturation of Phase-Separated Liquid Droplets by RNA-Binding Proteins. *Mol. Cell* **2015**, *60*, 208–219. [CrossRef] [PubMed]

205. Matsumoto, T.; Matsukawa, K.; Watanabe, N.; Kishino, Y.; Kunugi, H.; Ihara, R.; Wakabayashi, T.; Hashimoto, T.; Iwatsubo, T. Self-assembly of FUS through its low-complexity domain contributes to neurodegeneration. *Hum. Mol. Genet.* **2018**, *27*, 1353–1365. [CrossRef]

206. Guo, L.; Kim, H.J.; Wang, H.; Monaghan, J.; Freyermuth, F.; Sung, J.C.; O'Donovan, K.; Fare, C.M.; Diaz, Z.; Singh, N.; et al. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains. *Cell* **2018**, *173*, 677–692. [CrossRef]

207. Couthouis, J.; Hart, M.P.; Shorter, J.; DeJesus-Hernandez, M.; Erion, R.; Oristano, R.; Liu, A.X.; Ramos, D.; Jethava, N.; Hosangadi, D.; et al. A yeast functional screen predicts new candidate ALS disease genes. *Proc. Natl. Acad. Sci. USA* **2011**, *108*, 20881–20890. [CrossRef]

208. Hennig, S.; Kong, G.; Mannen, T.; Sadowska, A.; Kobelke, S.; Blythe, A.; Knott, G.J.; Iyer, K.S.; Ho, D.; Newcombe, E.A.; et al. Prion-like domains in RNA binding proteins are essential for building subnuclear paraspeckles. *J. Cell Biol.* **2015**, *210*, 529–539. [CrossRef]

209. Schwartz, J.C.; Wang, X.; Podell, E.R.; Cech, T.R. RNA seeds higher-order assembly of FUS protein. *Cell Rep.* **2013**, *5*, 918–925. [CrossRef]

210. Boeynaems, S.; Alberti, S.; Fawzi, N.L.; Mittag, T.; Polymenidou, M.; Rousseau, F.; Schymkowitz, J.; Shorter, J.; Wolozin, B.; van den Bosch, L.; et al. Protein Phase Separation: A New Phase in Cell Biology. *Trends Cell Biol.* **2018**, *28*, 420–435. [CrossRef]

211. Molliex, A.; Temirov, J.; Lee, J.; Coughlin, M.; Kanagaraj, A.P.; Kim, H.J.; Mittag, T.; Taylor, J.P. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. *Cell* **2015**, *163*, 123–133. [CrossRef] [PubMed]

212. Patel, A.; Lee, H.O.; Jawerth, L.; Maharana, S.; Jahnel, M.; Hein, M.Y.; Stoynov, S.; Mahamid, J.; Saha, S.; Franzmann, T.M.; et al. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. *Cell* **2015**, *162*, 1066–1077. [CrossRef] [PubMed]

213. March, Z.M.; King, O.D.; Shorter, J. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. *Brain Res.* **2016**, *1647*, 9–18. [CrossRef] [PubMed]

214. Dudman, J.; Qi, X. Stress Granule Dysregulation in Amyotrophic Lateral Sclerosis. *Front. Cell. Neurosci.* **2020**, *14*, 598517. [CrossRef]

215. Hofmann, S.; Kedersha, N.; Anderson, P.; Ivanov, P. Molecular mechanisms of stress granule assembly and disassembly. *Biochim. Biophys. Acta. Mol. Cell Res.* **2021**, *1868*, 118876. [CrossRef] [PubMed]

216. Wolozin, B.; Ivanov, P. Stress granules and neurodegeneration. *Nature Rev. Neurosci.* **2019**, *20*, 649–666. [CrossRef]

217. Zhang, X.; Wang, F.; Hu, Y.; Chen, R.; Meng, D.; Guo, L.; Lv, H.; Guan, J.; Jia, Y. In vivo stress granule misprocessing evidenced in a FUS knock-in ALS mouse model. *Brain* **2020**, *143*, 1350–1367. [CrossRef]

218. Ratovitski, T.; O'Meally, R.N.; Jiang, M.; Chaerkady, R.; Chighladze, E.; Stewart, J.C.; Wang, X.; Arbez, N.; Roby, E.; Alexandris, A.; et al. Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats. *J. Proteome Res.* **2017**, *16*, 2692–2708. [CrossRef]

219. Barrett, P.J.; Timothy, G.J. Post-translational modification of α-synuclein in Parkinson's disease. *Brain Res.* **2015**, *1628*, 247–253. [CrossRef]

220. Correia, S.C.; Carvalho, C.; Cardoso, S.; Moreira, P.I. Post-translational modifications in brain health and disease. *Biochim. Biophys. Acta. Mol. Basis dis.* **2019**, *1865*, 1947–1948. [CrossRef]

221. Kurtishi, A.; Rosen, B.; Patil, K.S.; Alves, G.W.; Møller, S.G. Cellular Proteostasis in Neurodegeneration. *Mol. Neurobiol.* **2019**, *56*, 3676–3689. [CrossRef]
222. Wang, Y.; Mandelkow, E. Tau in physiology and pathology. *Nat. Rev. Neurosci.* **2016**, *17*, 5–21. [CrossRef] [PubMed]

223. Rhoads, S.N.; Monahan, Z.T.; Yee, D.S.; Shewmaker, F.P. The Role of Post-Translational Modifications on Prion-Like Aggregation and Liquid-Phase Separation of FUS. *Int. J. Mol. Sci.* **2018**, *19*, 886. [CrossRef]

224. Xue, Y.C.; Ng, C.S.; Xiang, P.; Liu, H.; Zhang, K.; Mohamud, Y.; Luo, H. Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis. *Front. Mol. Neurosci.* **2020**, *13*, 78. [CrossRef]

225. Dormann, D.; Madl, T.; Valori, C.F.; Bentmann, E.; Tahirovic, S.; Abou-Ajram, C.; Kremmer, E.; Ansorge, O.; Mackenzie, I.R.; Neumann, M.; et al. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. *EMBO J.* **2012**, *31*, 4258–4275. [CrossRef]

226. Hofweber, M.; Hutten, S.; Bourgeois, B.; Spreitzer, E.; Niedner-Boblenz, A.; Schifferer, M.; Ruepp, M.D.; Simons, M.; Niessing, D.; Madl, T.; et al. Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation. *Cell* **2018**, *173*, 706–719. [CrossRef]

227. Qamar, S.; Wang, G.; Randle, S.J.; Ruggeri, F.S.; Varela, J.A.; Lin, J.Q.; Phillips, E.C.; Miyashita, A.; Williams, D.; Ströhl, F.; et al. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions. *Cell* **2018**, *173*, 720–734. [CrossRef]

228. Boulanger, M.C.; Miranda, T.B.; Clarke, S.; di Fruscio, M.; Suter, B.; Lasko, P.; Richard, S. Characterization of the Drosophila protein arginine methyltransferases DART1 and DART4. *Biochem. J.* **2004**, *379*, 283–289. [CrossRef]

229. Scaramuzzino, C.; Casci, I.; Parodi, S.; Lievens, P.M.J.; Polanco, M.J.; Milioto, C.; Chivet, M.; Monaghan, J.; Mishra, A.; Badders, N.; et al. Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. *Neuron* **2015**, *85*, 88–100. [CrossRef]

230. Wang, Y.C.; Li, C. Evolutionarily conserved protein arginine methyltransferases in non-mammalian animal systems. *FEBS J.* **2012**, *279*, 932–945. [CrossRef]

231. Lo Piccolo, L.; Mochizuki, H.; Nagai, Y. The lncRNA hsrw regulates arginine dimethylation of human FUS to cause its proteasomal degradation in Drosophila. *J. Cell Sci.* **2019**, *132*, jcs236836. [CrossRef] [PubMed]

232. Braun, R.J.; Zischka, H. Mechanisms of Cdc48/VCP-mediated cell death: From yeast apoptosis to human disease. *Biochim. Biophys. Acta* **2008**, *1783*, 1418–1435. [CrossRef] [PubMed]

233. Kobayashi, H.; Tomari, Y. Identification of an AGO (Argonaute) protein as a prey of TER94/VCP. *Autophagy* **2020**, *16*, 190–192. [CrossRef] [PubMed]

234. Meyer, H.; Bug, M.; Bremer, S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. *Nature Cell Biol.* **2012**, *14*, 117–123. [CrossRef] [PubMed]

235. Johnson, J.O.; Mandrioli, J.; Benatar, M.; Abramzon, Y.; van Deerlin, V.M.; Trojanowski, J.Q.; Gibbs, J.R.; Brunetti, M.; Gronka, S.; Wuu, J.; et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. *Neuron* **2010**, *68*, 857–864. [CrossRef] [PubMed]

236. Harley, J.; Hagemann, C.; Serio, A.; Patani, R. FUS is lost from nuclei and gained in neurites of motor neurons in a human stem cell model of VCP-related ALS. *Brain* **2020**, *143*, e103. [CrossRef]

237. Tyzack, G.E.; Luisier, R.; Taha, D.M.; Neeves, J.; Modic, M.; Mitchell, J.S.; Meyer, I.; Greensmith, L.; Newcombe, J.; Ule, J.; et al. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. *Brain* **2019**, *142*, 2572–2580. [CrossRef]

238. Baillon, L.; Germani, F.; Rockel, C.; Hilchenbach, J.; Basler, K. Xrp1 is a transcription factor required for cell competition-driven elimination of loser cells. *Sci. Rep.* **2018**, *8*, 17712. [CrossRef]

239. Reeves, R. Nuclear functions of the HMG proteins. *Biochim. Biophys. Acta* **2010**, *1799*, 3–14. [CrossRef]

240. Mallik, M.; Catinozzi, M.; Hug, C.B.; Zhang, L.; Wagner, M.; Bussmann, J.; Bittern, J.; Mersmann, S.; Klämbt, C.; Drexler, H.C.A.; et al. Xrp1 genetically interacts with the ALS-associated FUS orthologue caz and mediates its toxicity. *J. Cell Biol.* **2018**, *217*, 3947–3964. [CrossRef]

241. Iwasaki, Y.W.; Murano, K.; Ishizu, H.; Shibuya, A.; Iyoda, Y.; Siomi, M.C.; Siomi, H.; Saito, K. Piwi Modulates Chromatin Accessibility by Regulating Multiple Factors Including Histone H1 to Repress Transposons. *Mol. Cell* **2016**, *63*, 408–419. [CrossRef] [PubMed]

242. Le, T.A.; Rogers, A.K.; Webster, A.; Marinov, G.K.; Liao, S.E.; Perkins, E.M.; Hur, J.K.; Aravin, A.A.; Tóth, K.F. Piwi induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin state. *Genes Dev.* **2013**, *27*, 390–399. [CrossRef]

243. Yamanaka, S.; Siomi, M.C.; Siomi, H. piRNA clusters and open chromatin structure. *Mob. DNA* **2014**, *5*, 22. [CrossRef] [PubMed]

244. Ghildiyal, M.; Seitz, H.; Horwich, M.D.; Li, C.; Du, T.; Lee, S.; Xu, J.; Kittler, E.L.; Zapp, M.L.; Weng, Z.; et al. Endogenous siRNAs derived from transposons and mRNAs in Drosophila somatic cells. *Science (New York, NY)* **2008**, *320*, 1077–1081. [CrossRef] [PubMed]

245. Perrat, P.N.; DasGupta, S.; Wang, J.; Theurkauf, W.; Weng, Z.; Rosbash, M.; Waddell, S. Transposition-driven genomic heterogeneity in the Drosophila brain. *Science (New York, NY)* **2013**, *340*, 91–95. [CrossRef] [PubMed]

246. Youle, R.J.; Narendra, D.P. Mechanisms of mitophagy. *Nat. Rev. Mol. Cell Biol.* **2011**, *12*, 9–14. [CrossRef]

247. Ma, X.; Chen, Y.; Xu, W.; Wu, N.; Li, M.; Cao, Y.; Wu, S.; Li, Q.; Xue, L. Impaired Hippo signaling promotes Rho1-JNK-dependent growth. *Proc. Natl. Acad. Sci. USA* **2015**, *112*, 1065–1070. [CrossRef] [PubMed]

248. Ma, X.; Wang, H.; Ji, J.; Xu, W.; Sun, Y.; Li, W.; Zhang, X.; Chen, J.; Xue, L. Hippo signaling promotes JNK-dependent cell migration. *Proc. Natl. Acad. Sci. USA* **2017**, *114*, 1934–1939. [CrossRef] [PubMed]
249. Kango-Singh, M.; Singh, A. Regulation of organ size: Insights from the Drosophila Hippo signaling pathway. *Dev. Dyn. Off. Publ. Am. Assoc. Anat.* **2009**, *238*, 1627–1637. [CrossRef]

250. Manning, S.A.; Kroeger, B.; Harvey, K.F. The regulation of Yorkie, YAP and TAZ: New insights into the Hippo pathway. *Development (Cambridge, UK)* **2020**, *147*. [CrossRef]

251. Sahu, M.R.; Mondal, A.C. The emerging role of Hippo signaling in neurodegeneration. *J. Neurosci. Res.* **2020**, *98*, 796–814. [CrossRef] [PubMed]

252. Brunet, M.A.; Jacques, J.F.; Nassari, S.; Tyzack, G.E.; McGoldrick, P.; Zinman, L.; Jean, S.; Robertson, J.; Patani, R.; Roucou, X. The FUS gene is dual-coding with both proteins contributing to FUS-mediated toxicity. *EMBO Rep.* **2020**, *22*, e50640. [CrossRef]

253. Arai, T.; Hasegawa, M.; Akiyama, H.; Ikeda, K.; Nonaka, T.; Mori, H.; Mann, D.; Tsuchiya, K.; Yoshida, M.; Hashizume, Y.; et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. *Biochem. Biophys. Res. Commun.* **2006**, *351*, 602–611. [CrossRef] [PubMed]

254. Gitcho, M.A.; Baloh, R.H.; Chakraverty, S.; Mayo, K.; Norton, J.B.; Levitch, D.; Hatanpaa, K.J.; White, C.L., 3rd; Bigio, E.H.; Caselli, R.; et al. TDP-43 A315T mutation in familial motor neuron disease. *Ann. Neurol.* **2008**, *63*, 535–538. [CrossRef] [PubMed]

255. Kabashi, E.; Valdmanis, P.N.; Dion, P.; Spiegelman, D.; McConkey, B.J.; Vande Velde, C.; Bouchard, J.P.; Lacomblez, L.; Pochigaeva, K.; Salachas, F.; et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. *Nat. Genet.* **2008**, *40*, 572–574. [CrossRef] [PubMed]

256. Rutherford, N.J.; Zhang, Y.J.; Baker, M.; Gass, J.M.; Finch, N.A.; Xu, Y.F.; Stewart, H.; Kelley, B.J.; Kuntz, K.; Crook, R.J.; et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. *PLoS Genet.* **2008**, *4*, e1000193. [CrossRef]

257. Sreedharan, J.; Blair, I.P.; Tripathi, V.B.; Hu, X.; Vance, C.; Rogelj, B.; Ackerley, S.; Durnall, J.C.; Williams, K.L.; Buratti, E.; et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. *Science (New York, NY)* **2008**, *319*, 1668–1672. [CrossRef]

258. Van Deerlin, V.M.; Leverenz, J.B.; Bekris, L.M.; Bird, T.D.; Yuan, W.; Elman, L.B.; Clay, D.; Wood, E.M.; Chen-Plotkin, A.S.; Martinez-Lage, M.; et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis. *Lancet Neurol.* **2008**, *7*, 409–416. [CrossRef]

259. Yokoseki, A.; Shiga, A.; Tan, C.F.; Tagawa, A.; Kaneko, H.; Koyama, A.; Eguchi, H.; Tsujino, A.; Ikeuchi, T.; Kakita, A.; et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. *Ann. Neurol.* **2008**, *63*, 538–542. [CrossRef]

260. Kapeli, K.; Martinez, F.J.; Yeo, G.W. Genetic mutations in RNA-binding proteins and their roles in ALS. *Human Genet.* **2017**, *136*, 1193–1214. [CrossRef]

261. Picher-Martel, V.; Valdmanis, P.N.; Gould, P.V.; Julien, J.P.; Dupré, N. From animal models to human disease: A genetic approach for personalized medicine in ALS. *Acta Neuropathol. Commun.* **2016**, *4*, 70. [CrossRef] [PubMed]

262. Buratti, E.; Baralle, F.E. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. *RNA Biol.* **2010**, *7*, 420–429. [CrossRef] [PubMed]

263. Suk, T.R.; Rousseaux, M.W.C. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. *Molecular Neurodegener.* **2020**, *15*, 45. [CrossRef] [PubMed]

264. Wang, H.Y.; Wang, I.F.; Bose, J.; Shen, C.K. Structural diversity and functional implications of the eukaryotic TDP gene family. *Genomics* **2004**, *83*, 130–139. [CrossRef]

265. Lin, M.J.; Cheng, C.W.; Shen, C.K. Neuronal function and dysfunction of Drosophila dTDP. *PLoS ONE* **2011**, *6*, e20371. [CrossRef]

266. Diaper, D.C.; Adachi, Y.; Sutcliffe, B.; Humphrey, D.M.; Elliott, C.J.; Stepto, A.; Ludlow, Z.N.; Vanden, B.L.; Callaerts, P.; Dermaut, B.; et al. Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes. *Hum. Mol. Genet.* **2013**, *22*, 1539–1557. [CrossRef]

267. Feiguin, F.; Godena, V.K.; Romano, G.; D'Ambrogio, A.; Klima, R.; Baralle, F.E. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. *FEBS Lett.* **2009**, *583*, 1586–1592. [CrossRef]

268. Fiesel, F.C.; Voigt, A.; Weber, S.S.; van den Haute, C.; Waldenmaier, A.; Görner, K.; Walter, M.; Anderson, M.L.; Kern, J.V.; Rasse, T.M.; et al. Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. *EMBO J.* **2010**, *29*, 209–221. [CrossRef]

269. Kushimura, Y.; Tokuda, T.; Azuma, Y.; Yamamoto, I.; Mizuta, I.; Mizuno, T.; Nakagawa, M.; Ueyama, M.; Nagai, Y.; Yoshida, H.; et al. Overexpression of ter94, Drosophila VCP, improves motor neuron degeneration induced by knockdown of *TBPH*, Drosophila TDP-43. *Am. J. Neurodegener. Dis.* **2018**, *7*, 11–31. [PubMed]

270. Diaper, D.C.; Adachi, Y.; Lazarou, L.; Greenstein, M.; Simoes, F.A.; di Domenico, A.; Solomon, D.A.; Lowe, S.; Alsubaie, R.; Cheng, D.; et al. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. *Hum. Mol. Genet.* **2013**, *22*, 3883–3893. [CrossRef]

271. Romano, G.; Appocher, C.; Scorzeto, M.; Klima, R.; Baralle, F.E.; Megighian, A.; Feiguin, F. Glial TDP-43 regulates axon wrapping, GluRIIA clustering and fly motility by autonomous and non-autonomous mechanisms. *Hum. Mol. Genet.* **2015**, *24*, 6134–6145. [CrossRef] [PubMed]

272. Llamusi, B.; Bargiela, A.; Fernandez-Costa, J.M.; Garcia-Lopez, A.; Klima, R.; Feiguin, F.; Artero, R. Muscleblind, BSF and *TBPH* are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model. *Dis. Models Mech.* **2013**, *6*, 184–196. [CrossRef] [PubMed]
273. Wang, S.J.H.; Sinclair, D.A.R.; Kim, H.Y.; Kinsey, S.D.; Yoo, B.; Shih, C.R.Y.; Wong, K.K.L.; Krieger, C.; Harden, N.; Verheyen, E.M. Homeodomain-interacting protein kinase (Hipk) plays roles in nervous system and muscle structure and function. *PLoS ONE* **2020**, *15*, e0221006. [CrossRef] [PubMed]

274. Lu, Y.; Ferris, J.; Gao, F.B. Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching. *Mol. Brain* **2009**, *2*, 30. [CrossRef] [PubMed]

275. Hazelett, D.J.; Chang, J.C.; Lakeland, D.L.; Morton, D.B. Comparison of parallel high-throughput RNA sequencing between knockout of TDP-43 and its overexpression reveals primarily nonreciprocal and nonoverlapping gene expression changes in the central nervous system of Drosophila. *G3 Genes Genomes Genet.* **2012**, *2*, 789–802. [CrossRef] [PubMed]

276. Vanden, B.L.; Naval-Sánchez, M.; Adachi, Y.; Diaper, D.; Dourlen, P.; Chapuis, J.; Kleinberger, G.; Gistelinck, M.; van Broeckhoven, C.; Lambert, J.C.; et al. TDP-43 loss-of-function causes neuronal loss due to defective steroid receptor-mediated gene program switching in Drosophila. *Cell Rep.* **2013**, *3*, 160–172. [CrossRef]

277. Chang, J.C.; Hazelett, D.J.; Stewart, J.A.; Morton, D.B. Motor neuron expression of the voltage-gated calcium channel cacophony restores locomotion defects in a Drosophila, TDP-43 loss of function model of ALS. *Brain Res.* **2014**, *1584*, 39–51. [CrossRef]

278. Lembke, K.M.; Scudder, C.; Morton, D.B. Restoration of Motor Defects Caused by Loss of Drosophila TDP-43 by Expression of the Voltage-Gated Calcium Channel, Cacophony, in Central Neurons. *J. Neurosci.* **2017**, *37*, 9486–9497. [CrossRef]

279. Godena, V.K.; Romano, G.; Romano, M.; Appocher, C.; Klima, R.; Buratti, E.; Baralle, F.E.; Feiguin, F. TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch/MAP1B levels and synaptic microtubules organization. *PLoS ONE* **2011**, *6*, e17808. [CrossRef]

280. Donde, A.; Sun, M.; Ling, J.P.; Braunstein, K.E.; Pang, B.; Wen, X.; Cheng, X.; Chen, L.; Wong, P.C. Splicing repression is a major function of TDP-43 in motor neurons. *Acta Neuropathol.* **2019**, *138*, 813–826. [CrossRef]

281. Deshpande, M.; Feiger, Z.; Shilton, A.K.; Luo, C.C.; Silverman, E.; Rodal, A.A. Role of BMP receptor traffic in synaptic growth defects in an ALS model. *Mol. Biol. Cell* **2016**, *27*, 2898–2910. [CrossRef] [PubMed]

282. Strah, N.; Romano, G.; Introna, C.; Klima, R.; Marzullo, M.; Ciapponi, L.; Megighian, A.; Nizzardo, M.; Feiguin, F. TDP-43 promotes the formation of neuromuscular synapses through the regulation of Disc-large expression in Drosophila skeletal muscles. *BMC Biol.* **2020**, *18*, 34. [CrossRef]

283. Neumann, M.; Kwong, L.K.; Truax, A.C.; Vanmassenhove, B.; Kretzschmar, H.A.; van Deerlin, V.M.; Clark, C.M.; Grossman, M.; Miller, B.L.; Trojanowski, J.Q.; et al. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. *J. Neuropathol. Exp. Neurol.* **2007**, *66*, 177–183. [CrossRef] [PubMed]

284. Nishihira, Y.; Tan, C.F.; Onodera, O.; Toyoshima, Y.; Yamada, M.; Morita, T.; Nishizawa, M.; Kakita, A.; Takahashi, H. Sporadic amyotrophic lateral sclerosis: Two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. *Acta Neuropathol.* **2008**, *116*, 169–182. [CrossRef] [PubMed]

285. Zhang, H.; Tan, C.F.; Mori, F.; Tanji, K.; Kakita, A.; Takahashi, H.; Wakabayashi, K. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. *Acta Neuropathol.* **2008**, *115*, 115–122. [CrossRef] [PubMed]

286. Romano, G.; Klima, R.; Feiguin, F. TDP-43 prevents retrotransposon activation in the Drosophila motor system through regulation of Dicer-2 activity. *BMC Biol.* **2020**, *18*, 82. [CrossRef] [PubMed]

287. Li, Z.; Lu, Y.; Xu, X.L.; Gao, F.B. The FTD/ALS-associated RNA-binding protein TDP-43 regulates the robustness of neuronal specification through microRNA-9a in Drosophila. *Hum. Mol. Genet.* **2013**, *22*, 218–225. [CrossRef]

288. Romano, G.; Klima, R.; Buratti, E.; Verstreken, P.; Baralle, F.E.; Feiguin, F. Chronological requirements of TDP-43 function in synaptic organization and locomotive control. *Neurobiol. Dis.* **2014**, *71*, 95–109. [CrossRef]

289. Estes, P.S.; Boehringer, A.; Zwick, R.; Tang, J.E.; Grigsby, B.; Zarnescu, D.C. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. *Hum. Mol. Genet.* **2011**, *20*, 2308–2321. [CrossRef]

290. Li, Y.; Ray, P.; Rao, E.J.; Shi, C.; Guo, W.; Chen, X.; Woodruff, E.A., 3rd; Fushimi, K.; Wu, J.Y. A Drosophila model for TDP-43 proteinopathy. *Proc. Natl. Acad. Sci. USA* **2010**, *107*, 3169–3174. [CrossRef]

291. Sreedharan, J.; Neukomm, L.J.; Brown, R.H., Jr.; Freeman, M.R. Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2. *Curr. Biol.* **2015**, *25*, 2130–2136. [CrossRef] [PubMed]

292. Ritson, G.P.; Custer, S.K.; Freibaum, B.D.; Guinto, J.B.; Geffel, D.; Moore, J.; Tang, W.; Winton, M.J.; Neumann, M.; Trojanowski, J.Q.; et al. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. *J. Neurosci.* **2010**, *30*, 7729–7739. [CrossRef] [PubMed]

293. Ihara, R.; Matsukawa, K.; Nagata, Y.; Kunugi, H.; Tsuji, S.; Chihara, T.; Kuranaga, E.; Miura, M.; Wakabayashi, T.; Hashimoto, T.; et al. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy. *Hum. Mol. Genet.* **2013**, *22*, 4474–4484. [CrossRef]

294. Li, Y.; Wang, F.; Lee, J.A.; Gao, F.B. MicroRNA-9a ensures the precise specification of sensory organ precursors in Drosophila. *Genes Dev.* **2006**, *20*, 2793–2805. [CrossRef] [PubMed]

295. King, I.N.; Yartseva, V.; Salas, D.; Kumar, A.; Heidersbach, A.; Ando, D.M.; Stallings, N.R.; Elliott, J.L.; Srivastava, D.; Ivey, K.N. The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex. *J. Biol. Chem.* **2014**, *289*, 14263–14271. [CrossRef]
296. Alami, N.H.; Smith, R.B.; Carrasco, M.A.; Williams, L.A.; Winborn, C.S.; Han, S.S.W.; Kiskinis, E.; Winborn, B.; Freibaum, B.D.; Kanagaraj, A.; et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. *Neuron* **2014**, *81*, 536–543. [CrossRef]

297. Chang, J.C.; Morton, D.B. Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects. *PLoS ONE* **2017**, *12*, e0180828. [CrossRef]

298. Romano, M.; Buratti, E.; Romano, G.; Klima, R.; del Bel Belluz, L.; Stuani, C.; Baralle, F.; Feiguin, F. Evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) A/B proteins functionally interact with human and Drosophila TAR DNA-binding protein 43 (TDP-43). *J. Biol. Chem.* **2014**, *289*, 7121–7130. [CrossRef]

299. D'Ambrogio, A.; Buratti, E.; Stuani, C.; Guarnaccia, C.; Romano, M.; Ayala, Y.M.; Baralle, F.E. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. *Nucleic Acids Res.* **2009**, *37*, 4116–4126. [CrossRef]

300. Ayala, Y.M.; Pantano, S.; D'Ambrogio, A.; Buratti, E.; Brindisi, A.; Marchetti, C.; Romano, M.; Baralle, F.E. Human, Drosophila, and C. elegans TDP43: Nucleic acid binding properties and splicing regulatory function. *J. Mol. Biol.* **2005**, *348*, 575–588. [CrossRef]

301. Cheng, C.W.; Lin, M.J.; Shen, C.K. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP. *J. Neurogener.* **2015**, *29*, 59–68. [CrossRef] [PubMed]

302. Kankel, M.W.; Sen, A.; Lu, L.; Theodorou, M.; Dimlich, D.N.; McCampbell, A.; Henderson, C.E.; Shneider, N.A.; Artavanis-Tsakonas, S. Amyotrophic Lateral Sclerosis Modifiers in Drosophila Reveal the Phospholipase D Pathway as a Potential Therapeutic Target. *Genetics* **2020**, *215*, 747–766. [CrossRef] [PubMed]

303. Appocher, C.; Mohagheghi, F.; Cappelli, S.; Stuani, C.; Romano, M.; Feiguin, F.; Buratti, E. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. *Nucleic Acids Res.* **2017**, *45*, 8026–8045. [CrossRef] [PubMed]

304. Cragnaz, L.; Klima, R.; Skoko, N.; Budini, M.; Feiguin, F.; Baralle, F.E. Aggregate formation prevents dTDP-43 neurotoxicity in the Drosophila melanogaster eye. *Neurobiol. Dis.* **2014**, *71*, 74–80. [CrossRef]

305. Voigt, A.; Herholz, D.; Fiesel, F.C.; Kaur, K.; Müller, D.; Karsten, P.; Weber, S.S.; Kahle, P.J.; Marquardt, T.; Schulz, J.B. TDP-43-mediated neuron loss in vivo requires RNA-binding activity. *PLoS ONE* **2010**, *5*, e12247. [CrossRef]

306. Choksi, D.K.; Roy, B.; Chatterjee, S.; Yusuff, T.; Bakhoum, M.F.; Sengupta, U.; Ambegaokar, S.; Kayed, R.; Jackson, G.R. TDP-43 Phosphorylation by casein kinase Iε promotes oligomerization and enhances toxicity in vivo. *Hum. Mol. Genet.* **2014**, *23*, 1025–1035. [CrossRef]

307. Miguel, L.; Frébourg, T.; Campion, D.; Lecourtois, M. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies. *Neurobiol. Dis.* **2011**, *41*, 398–406. [CrossRef]

308. Elden, A.C.; Kim, H.J.; Hart, M.P.; Chen-Plotkin, A.S.; Johnson, B.S.; Fang, X.; Armakola, M.; Geser, F.; Greene, R.; Lu, M.M.; et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. *Nature* **2010**, *466*, 1069–1075. [CrossRef]

309. Krug, L.; Chatterjee, N.; Borges-Monroy, R.; Hearn, S.; Liao, W.W.; Morrill, K.; Prazak, L.; Rozhkov, N.; Theodorou, D.; Hammell, M.; et al. Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. *PLoS Genet.* **2017**, *13*, e1006635. [CrossRef]

310. McGurk, L.; Gomes, E.; Guo, L.; Mojsilovic-Petrovic, J.; Tran, V.; Kalb, R.G.; Shorter, J.; Bonini, N.M. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. *Mol. Cell* **2018**, *71*, 703–717. [CrossRef]

311. Khalil, B.; Cabirol-Pol, M.J.; Miguel, L.; Whitworth, A.J.; Lecourtois, M.; Liévens, J.C. Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies. *Neurobiol. Aging* **2017**, *54*, 71–83. [CrossRef]

312. Wang, P.; Deng, J.; Dong, J.; Liu, J.; Bigio, E.H.; Mesulam, M.; Wang, T.; Sun, L.; Wang, L.; Lee, A.Y.; et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. *PLoS Genet.* **2019**, *15*, e1007947. [CrossRef] [PubMed]

313. Zhan, L.; Hanson, K.A.; Kim, S.H.; Tare, A.; Tibbetts, R.S. Identification of genetic modifiers of TDP-43 neurotoxicity in Drosophila. *PLoS ONE* **2013**, *8*, e57214. [CrossRef] [PubMed]

314. Kim, H.J.; Raphael, A.R.; LaDow, E.S.; McGurk, L.; Weber, R.A.; Trojanowski, J.Q.; Lee, V.M.; Finkbeiner, S.; Gitler, A.D.; Bonini, N.M. Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. *Nat. Genet.* **2014**, *46*, 152–160. [CrossRef] [PubMed]

315. Hanson, K.A.; Kim, S.H.; Wassarman, D.A.; Tibbetts, R.S. Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS). *J. Biol. Chem.* **2010**, *285*, 11068–11072. [CrossRef] [PubMed]

316. Cha, S.J.; Han, Y.J.; Choi, H.J.; Kim, H.J.; Kim, K. Glutathione S-Transferase Rescues Motor Neuronal Toxicity in Fly Model of Amyotrophic Lateral Sclerosis. *Antioxidants (Basel, Switzerland)* **2020**, *9*, 615. [CrossRef] [PubMed]

317. Chou, C.C.; Zhang, Y.; Umoh, M.E.; Vaughan, S.W.; Lorenzini, I.; Liu, F.; Sayegh, M.; Donlin-Asp, P.G.; Chen, Y.H.; Duong, D.M.; et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. *Nat. Neurosci.* **2018**, *21*, 228–239. [CrossRef]
318. Coyne, A.N.; Yamada, S.B.; Siddegowda, B.B.; Estes, P.S.; Zaepfel, B.L.; Johannesmeyer, J.S.; Lockwood, D.B.; Pham, L.T.; Hart, M.P.; Cassel, J.A.; et al. Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation. *Hum. Mol. Genet.* **2015**, *24*, 6886–6898. [CrossRef]

319. Liu, G.; Coyne, A.N.; Pei, F.; Vaughan, S.; Chaung, M.; Zarnescu, D.C.; Buchan, J.R. Endocytosis regulates TDP-43 toxicity and turnover. *Nat. Commun.* **2017**, *8*, 2092. [CrossRef]

320. Gregory, J.M.; Barros, T.P.; Meehan, S.; Dobson, C.M.; Luheshi, L.M. The aggregation and neurotoxicity of TDP-43 and its ALS-associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila. *PLoS ONE* **2012**, *7*, e31899. [CrossRef]

321. Wang, C.; Duan, Y.; Duan, G.; Wang, Q.; Zhang, K.; Deng, X.; Qian, B.; Gu, J.; Ma, Z.; Zhang, S.; et al. Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation. *Mol. Cell* **2020**, *79*, 443–458. [CrossRef] [PubMed]

322. Kim, S.H.; Zhan, L.; Hanson, K.A.; Tibbetts, R.S. High-content RNAi screening identifies the Type 1 inositol triphosphate receptor as a modifier of TDP-43 localization and neurotoxicity. *Hum. Mol. Genet.* **2012**, *21*, 4845–4856. [CrossRef] [PubMed]

323. Zhan, L.; Xie, Q.; Tibbetts, R.S. Opposing roles of p38 and JNK in a Drosophila model of TDP-43 proteinopathy reveal oxidative stress and innate immunity as pathogenic components of neurodegeneration. *Hum. Mol. Genet.* **2015**, *24*, 757–772. [CrossRef] [PubMed]

324. Gregory, J.M.; Whiten, D.R.; Brown, R.A.; Barros, T.P.; Kumita, J.R.; Yerbury, J.J.; Satapathy, S.; McDade, K.; Smith, C.; Luheshi, L.M.; et al. Clusterin protects neurons against intracellular proteotoxicity. *Acta Neuropathol. Commun.* **2017**, *5*, 81. [CrossRef] [PubMed]

325. Lee, S.; Kim, S.; Kang, H.Y.; Lim, H.R.; Kwon, Y.; Jo, M.; Jeon, Y.M.; Kim, S.R.; Kim, K.; Ha, C.M.; et al. The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response. *J. Neuroinflamm.* **2020**, *17*, 299. [CrossRef]

326. Chang, Y.H.; Dubnau, J. The Gypsy Endogenous Retrovirus Drives Non-Cell-Autonomous Propagation in a Drosophila TDP-43 Model of Neurodegeneration. *Curr. Biol.* **2019**, *29*, 3135–3152. [CrossRef]

327. Crippa, V.; Cicardi, M.E.; Ramesh, N.; Seguin, S.J.; Ganassi, M.; Bigi, I.; Diacci, C.; Zelotti, E.; Baratashvili, M.; Gregory, J.M.; et al. The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity. *Hum. Mol. Genet.* **2016**, *25*, 3908–3924. [CrossRef]

328. Sanna, S.; Esposito, S.; Masala, A.; Sini, P.; Nieddu, G.; Galioto, M.; Fais, M.; Iaccarino, C.; Cestra, G.; Crosio, C. HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo. *Cell Death Dis.* **2020**, *11*, 369. [CrossRef]

329. Tazelaar, G.H.P.; Boeynaems, S.; de Decker, M.; van Vugt, J.; Kool, L.; Goedee, H.S.; McLaughlin, R.L.; Sproviero, W.; Iacoangeli, A.; Moisse, M.; et al. ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization. *Brain Commun.* **2020**, *2*, fcaa064. [CrossRef]

330. Berson, A.; Sartoris, A.; Nativio, R.; van Deerlin, V.; Toledo, J.B.; Porta, S.; Liu, S.; Chung, C.Y.; Garcia, B.A.; Lee, V.M.; et al. TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling. *Curr. Biol.* **2017**, *27*, 3579–3590. [CrossRef]

331. Chou, C.C.; Alexeeva, O.M.; Yamada, S.; Pribadi, A.; Zhang, Y.; Mo, B.; Williams, K.R.; Zarnescu, D.C.; Rossoll, W. PABPN1 suppresses TDP-43 toxicity in ALS disease models. *Hum. Mol. Genet.* **2015**, *24*, 5154–5173. [CrossRef] [PubMed]

332. Hans, F.; Fiesel, F.C.; Strong, J.C.; Jäckel, S.; Rasse, T.M.; Geisler, S.; Springer, W.; Schulz, J.B.; Voigt, A.; Kahle, P.J. UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination. *J. Biol. Chem.* **2014**, *289*, 19164–19179. [CrossRef] [PubMed]

333. Pons, M.; Miguel, L.; Miel, C.; Avequin, T.; Juge, F.; Frebourg, T.; Campion, D.; Lecourtois, M. Splicing factors act as genetic modulators of TDP-43 production in a new autoregulatory TDP-43 Drosophila model. *Hum. Mol. Genet.* **2017**, *26*, 3396–3408. [CrossRef] [PubMed]

334. Uechi, H.; Kuranaga, E.; Iriki, T.; Takano, K.; Hirayama, S.; Miura, M.; Hamazaki, J.; Murata, S. Ubiquitin-Binding Protein CG5445 Suppresses Aggregation and Cytotoxicity of Amyotrophic Lateral Sclerosis-Linked TDP-43 in Drosophila. *Mol. Cell. Biol.* **2018**, *38*. [CrossRef] [PubMed]

335. Coyne, A.N.; Siddegowda, B.B.; Estes, P.S.; Johannesmeyer, J.; Kovalik, T.; Daniel, S.G.; Pearson, A.; Bowser, R.; Zarnescu, D.C. Futsch/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. *J. Neurosci.* **2014**, *34*, 15962–15974. [CrossRef] [PubMed]

336. Estes, P.S.; Daniel, S.G.; McCallum, A.P.; Boehringer, A.V.; Sukhina, A.S.; Zwick, R.A.; Zarnescu, D.C. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis. *Dis. Models Mech.* **2013**, *6*, 721–733. [CrossRef]

337. Coyne, A.N.; Lorenzini, I.; Chou, C.C.; Torvund, M.; Rogers, R.S.; Starr, A.; Zaepfel, B.L.; Levy, J.; Johannesmeyer, J.; Schwartz, J.C.; et al. Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS. *Cell Rep.* **2017**, *21*, 110–125. [CrossRef]

338. Cragnaz, L.; Klima, R.; de Conti, L.; Romano, G.; Feiguin, F.; Buratti, E.; Baralle, M.; Baralle, F.E. An age-related reduction of brain *TBPH/TDP-43* levels precedes the onset of locomotion defects in a Drosophila ALS model. *Neuroscience* **2015**, *311*, 415–421. [CrossRef]

339. Staněk, D.; Fox, A.H. Nuclear bodies: News insights into structure and function. *Curr. Opin. Cell Biol.* **2017**, *46*, 94–101. [CrossRef]

340. Miskiewicz, K.; Jose, L.E.; Yeshaw, W.M.; Valadas, J.S.; Swerts, J.; Munck, S.; Feiguin, F.; Dermaut, B.; Verstreken, P. HDAC6 is a Bruchpilot deacetylase that facilitates neurotransmitter release. *Cell Rep.* **2014**, *8*, 94–102. [CrossRef]
341. Baldwin, K.R.; Godena, V.K.; Hewitt, V.L.; Whitworth, A.J. Axonal transport defects are a common phenotype in Drosophila models of ALS. *Hum. Mol. Genet.* **2016**, *25*, 2378–2392. [CrossRef] [PubMed]

342. Romano, G.; Holodkov, N.; Klima, R.; Grilli, F.; Guarnaccia, C.; Nizzardo, M.; Rizzo, F.; Garcia, R.; Feiguin, F. Downregulation of glutamic acid decarboxylase in Drosophila TDP-43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses. *Sci. Rep.* **2018**, *8*, 1809. [CrossRef]

343. Holcik, M.; Sonenberg, N. Translational control in stress and apoptosis. *Nat. Rev. Mol. Cell Biol.* **2005**, *6*, 318–327. [CrossRef] [PubMed]

344. Kedersha, N.; Chen, S.; Gilks, N.; Li, W.; Miller, I.J.; Stahl, J.; Anderson, P. Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules. *Mol. Biol. Cell* **2002**, *13*, 195–210. [CrossRef] [PubMed]

345. Lai, A.; Valdez-Sinon, A.N.; Bassell, G.J. Regulation of RNA granules by FMRP and implications for neurological diseases. *Traffic* (Copenhagen, Denmark) **2020**, *21*, 454–462. [CrossRef] [PubMed]

346. Kaehler, C.; Isensee, J.; Nonhoff, U.; Terrey, M.; Hucho, T.; Lehrach, H.; Krobitsch, S. Ataxin-2-like is a regulator of stress granules and processing bodies. *PLoS ONE* **2012**, *7*, e50134. [CrossRef]

347. Nonhoff, U.; Ralser, M.; Welzel, F.; Piccini, I.; Balzereit, D.; Yaspo, M.L.; Lehrach, H.; Krobitsch, S. Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. *Mol. Biol. Cell* **2007**, *18*, 1385–1396. [CrossRef]

348. Becker, L.A.; Huang, B.; Bieri, G.; Ma, R.; Knowles, D.A.; Jafar-Nejad, P.; Messing, J.; Kim, H.J.; Soriano, A.; Auburger, G.; et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. *Nature* **2017**, *544*, 367–371. [CrossRef]

349. Banerjee, A.; Apponi, L.H.; Pavlath, G.K.; Corbett, A.H. PABPN1: Molecular function and muscle disease. *FEBS J.* **2013**, *280*, 4230–4250. [CrossRef]

350. Kim, S.H.; Shanware, N.P.; Bowler, M.J.; Tibbetts, R.S. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. *J. Biol. Chem.* **2010**, *285*, 34097–34105. [CrossRef]

351. Duan, Y.; Du, A.; Gu, J.; Duan, G.; Wang, C.; Gui, X.; Ma, Z.; Qian, B.; Deng, X.; Zhang, K.; et al. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. *Cell Res.* **2019**, *29*, 233–247. [CrossRef]

352. Inukai, Y.; Nonaka, T.; Arai, T.; Yoshida, M.; Hashizume, Y.; Beach, T.G.; Buratti, E.; Baralle, F.E.; Akiyama, H.; Hisanaga, S.; et al. Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. *FEBS Lett.* **2008**, *582*, 2899–2904. [CrossRef]

353. Budini, M.; Buratti, E.; Stuani, C.; Guarnaccia, C.; Romano, V.; de Conti, L.; Baralle, F.E. Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region. *J. Biol. Chem.* **2012**, *287*, 7512–7525. [CrossRef]

354. Nizard, P.; Tetley, S.; Le Dréan, Y.; Watrin, T.; Le Goff, P.; Wilson, M.R.; Michel, D. Stress-induced retrotranslocation of clusterin/ApoJ into the cytosol. *Traffic* (Copenhagen, Denmark) **2007**, *8*, 554–565. [CrossRef]

355. Song, G.J.; Jung, M.; Kim, J.H.; Park, H.; Rahman, M.H.; Zhang, S.; Zhang, Z.Y.; Park, D.H.; Kook, H.; Lee, I.K.; et al. A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation. *J. Neuroinflamm.* **2016**, *13*, 86. [CrossRef]

356. Hay, N.; Sonenberg, N. Upstream and downstream of mTOR. *Genes Dev.* **2004**, *18*, 1926–1945. [CrossRef]

357. Morettini, S.; Tribus, M.; Zeilner, A.; Sebald, J.; Campo-Fernandez, B.; Scheran, G.; Wörle, H.; Podhraski, V.; Fyodorov, D.V.; Lusser, A. The chromodomains of CHD1 are critical for enzymatic activity but less important for chromatin localization. *Nucleic Acids Res.* **2011**, *39*, 3103–3115. [CrossRef]

358. Körner, S.; Hendricks, M.; Kollewe, K.; Zapf, A.; Dengler, R.; Silani, V.; Petri, S. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): Impact on quality of life and therapeutic options. *BMC Neurol.* **2013**, *13*, 84. [CrossRef]

359. Bouteloup, C.; Desport, J.C.; Clavelou, P.; Guy, N.; Derumeaux-Burel, H.; Ferrier, A.; Couratier, P. Hypermetabolism in ALS patients: An early and persistent phenomenon. *J. Neurol.* **2009**, *256*, 1236–1242. [CrossRef]

360. Desport, J.C.; Preux, P.M.; Magy, L.; Boirie, Y.; Vallat, J.M.; Beaufrère, B.; Couratier, P. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. *Am. J. Clin. Nutr.* **2001**, *74*, 328–334. [CrossRef]

361. Pradat, P.F.; Bruneteau, G.; Gordon, P.H.; Dupuis, L.; Bonnefont-Rousselot, D.; Simon, D.; Salachas, F.; Corcia, P.; Frochot, V.; Lacorte, J.M.; et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. *Amyotroph. Lateral Scler.* **2010**, *11*, 166–171. [CrossRef]

362. Dupuis, L.; Corcia, P.; Fergani, A.; Gonzalez de Aguilar, J.L.; Bonnefont-Rousselot, D.; Bittar, R.; Seilhean, D.; Hauw, J.J.; Lacomblez, L.; Loeffler, J.P.; et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. *Neurology* **2008**, *70*, 1004–1009. [CrossRef]

363. Manzo, E.; Lorenzini, I.; Barrameda, D.; O’Conner, A.G.; Barrows, J.M.; Starr, A.; Kovalik, T.; Rabichow, B.E.; Lehmkuhl, E.M.; Shreiner, D.D.; et al. Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. *eLife* **2019**, *8*. [CrossRef]

364. Manzo, E.; O’Conner, A.G.; Barrows, J.M.; Shreiner, D.D.; Birchak, G.J.; Zarnescu, D.C. Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43. *Front. Mol. Neurosci.* **2018**, *11*, 182. [CrossRef]

365. Brouns, M.R.; Matheson, S.F.; Settleman, J. p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculation. *Nat. Cell Biol.* **2001**, *3*, 361–367. [CrossRef]
366. Langellotti, S.; Romano, G.; Feiguin, F.; Baralle, F.E.; Romano, M. RhoGAPp190: A potential player in tbph-mediated neurodegeneration in Drosophila. *PLoS ONE* **2018**, *13*, e0195845. [CrossRef]

367. Romano, M.; Feiguin, F.; Buratti, E. *TBPH/TDP-43* modulates translation of Drosophila futsch mRNA through an UG-rich sequence within its 5'UTR. *Brain Res.* **2016**, *1647*, 50-56. [CrossRef]

368. Boyault, C.; Zhang, Y.; Fritah, S.; Caron, C.; Gilquin, B.; Kwon, S.H.; Garrido, C.; Yao, T.P.; Vourc'h, C.; Matthias, P.; et al. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. *Genes Dev.* **2007**, *21*, 2172-2181. [CrossRef]

369. Kittel, R.J.; Wichmann, C.; Rasse, T.M.; Fouquet, W.; Schmidt, M.; Schmid, A.; Wagh, D.A.; Pawlu, C.; Kellner, R.R.; Willig, K.I.; et al. Bruchpilot promotes active zone assembly, Ca2+ channel clustering, and vesicle release. *Science* (New York, NY) **2006**, *312*, 1051-1054. [CrossRef]

370. Lembke, K.M.; Law, A.D.; Ahrar, J.; Morton, D.B. Deletion of a specific exon in the voltage-gated calcium channel gene cacophony disrupts locomotion in Drosophila larvae. *J. Exp. Biol* **2019**, *222* Pt 1. [CrossRef]

371. Brenner, D.; Yilmaz, R.; Müller, K.; Grehl, T.; Petri, S.; Meyer, T.; Grosskreutz, J.; Weydt, P.; Ruf, W.; Neuwirth, C.; et al. Hot-spot KIF5A mutations cause familial ALS. *Brain* **2018**, *141*, 688-697. [CrossRef]

372. Nicolas, A.; Kenna, K.P.; Renton, A.E.; Ticozzi, N.; Faghri, F.; Chia, R.; Dominov, J.A.; Kenna, B.J.; Nalls, M.A.; Keagle, P.; et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. *Neuron* **2018**, *97*, 1268-1283. [CrossRef]